Skip to main content
Midas Edge

AETHLON MEDICAL INC

For the period ended Dec 31, 2025. Filed Feb 12, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2025 · Filed Feb 12, 2026

AEMD$5.49+0.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 6. EXHIBITS

(a) Exhibits. The following documents are filed as part of this report:

Incorporated by Reference
Exhibit Number · Exhibit Description · Form · SEC File No. · Exhibit Number · Date · Filed Herewith
3.1Articles of Incorporation, as amended8-K001-374873.1September 19, 2022
3.2Amended and Restated Bylaws of the Company8-K001-374873.1September 12, 2019
3.3Certificate of Change pursuant to NRS 78.2098-K001-374873.1October 16, 2025
4.1Form of Common Stock CertificateS-1333-2013344.1December 31, 2014
4.2Form of Warrant to Purchase Common StockS-1/A333-2347124.14December 11, 2019
4.3Form of Underwriter WarrantS-1/A333-2347124.15December 11, 2019
4.4Form of Common Stock Purchase Warrant8-K001-374874.1January 17, 2020
4.5Form of Class A Warrant to Purchase Common Stock, issued on May 17, 20248-K001-374874.1May 17, 2024
4.6Form of Class B Warrant to Purchase Common Stock, issued on May 17, 20248-K001-374874.2May 17, 2024
4.7Form of Pre-Funded Warrant to Purchase Common Stock, issued on May 17, 20248-K001-374874.3May 17, 2024
4.8Form of Common Warrant to Purchase Common Stock issued on September 4, 20258-K001-374874.1September 9, 2025
4.9Form of Pre-Funded Warrant issued on September 4, 20258-K001-374874.2September 9, 2025
4.10Placement Agent Warrant issued September 4, 20258-K001-374874.3September 9, 2025
4.11Form of Warrant Agency Agreement with ComputershareS-1/A333-2897454.13August 29, 2025
4.12Form of Common Warrant issued December 5, 20258-K001-374874.1December 8, 2025
4.13Form of Pre-Funded Warrant issued December 5, 20258-K001-374874.2December 8, 2025
4.14Amendment to Pre-Funded Warrant8-K001-3748710.2January 26, 2026
10.1Securities Purchase Agreement issued September 4, 20258-K001-3748710.1September 9, 2025
10.2Placement Agency Agreement dated September 4, 20258-K001-3748710.2September 9, 2025
10.3Placement Agency Agreement dated December 5, 20258-K001-374871.1December 8, 2025
10.4Form of Registration Rights Agreement dated December 5, 20258-K001-3748710.2December 8, 2025
10.5Form of Warrant Inducement Agreement8-K001-3748710.3December 8, 2025
10.6Form of Securities Purchase Agreement between the Company and purchaser signatory thereto8-K001-3748710.1December 8, 2025
10.7Amendment to Securities Purchase Agreement between the Company and the purchaser signatory thereto8-K001-3748710.1January 26, 2026
31.1Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934.X
32.1^Certification of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350.X
101.INSInline XBRL Instance Document with Embedded Linkbase DocumentsX
101.SCHInline XBRL Taxonomy Extension Schema DocumentX
104Cover Page Interactive Data File (formatted in XBRL, and included in exhibit 101)
^The information in Exhibit 32.1 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act (including this Quarterly Report), unless the Registrant specifically incorporates the foregoing information into those documents by reference.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.